Pazopanib Impurity 42 | CAS 1376676-65-1 - Request Quote
Pazopanib Impurity 42
| SZ CAT No: | SZ-P013058 |
| CAS No | 1376676-65-1 |
| Mol.F. | C10H13N3 |
| Mol.Wt. | 175.2 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1810075-93-4 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pazopanib Impurity 42 is chemically N,2,3-trimethyl-2H-indazol-6-amine. Pazopanib Impurity 42 is supplied with detailed characterization data compliant with regulatory guideline. Pazopanib Impurity 42 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pazopanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1376676-65-1
Purchase 1376676-65-1
Order 1376676-65-1
Enquire 1376676-65-1
price of 1376676-65-1
1376676-65-1 Supplier
1376676-65-1 Manufacturer
1376676-65-1 Exporter
buy high quality Pazopanib Impurity 42
Purchase Pazopanib Impurity 42
Pazopanib Impurity 42 suppliers
Pazopanib Impurity 42 manufacturers
Pazopanib Impurity 42 price
Order Pazopanib Impurity 42
Enquire Pazopanib Impurity 42
Pazopanib Impurity 42 cost
Pazopanib Impurity 42 Supplier
Pazopanib Impurity 42 Distributor
Pazopanib Impurity 42 for Method Validation
Pazopanib Reference Standard
Pazopanib Impurity 42 for ANDA Filing
Pazopanib Impurity 42 for Forced Degradation Studies
Pazopanib Impurity 42 Identification Standards
Pazopanib Impurity 42 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.